Sun, Jul 13, 2014, 5:59 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • lux19insm@rocketmail.com lux19insm Aug 22, 2013 10:45 AM Flag

    For the iPlex naysayers

    lets have a serious response instead of "iPlex is dead"

    how could we have an article on muscular dystrophy on june 25th 2013 about iPlex if iPlex is dead and the stock pile of iPlex has been depleted for well over 18 months? Your probably right that insm is not actively pursuing iPlex.....but somebody is!!

    Researchers Identify Novel Therapy to Treat Muscular Dystrophy

    The research team studied the outcome of combining the following single mode treatments: increasing regeneration, by overexpressing muscle specific insulin like growth factor-1, IGF-1 and preventing cell death, by inhibiting the expression of Bax, a pro-apoptotic protein. In addition, to test the translational potential of this combination therapy, the researchers systemically treated Bax deficient dystrophic mice with recombinant human IGF-1 (IPLEX TM, manufactured by Insmed Inc).

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
19.01+0.18(+0.96%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.